Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1982 May 15;284(6327):1423–1424. doi: 10.1136/bmj.284.6327.1423

The female carrier of Duchenne muscular dystrophy.

V Dubowitz
PMCID: PMC1498325  PMID: 6805547

Full text

PDF
1423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alberts M. C., Samaha F. J. Serum pyruvate kinase in muscle disease and carrier states. Neurology. 1974 May;24(5):462–464. doi: 10.1212/wnl.24.5.462. [DOI] [PubMed] [Google Scholar]
  2. Blyth H., Hughes B. P. Pregnancy and serum C.P.K. levels in potential carriers of severe X-linked muscular dystrophy. Lancet. 1971 Apr 24;1(7704):855–856. doi: 10.1016/s0140-6736(71)91520-0. [DOI] [PubMed] [Google Scholar]
  3. DREYFUS J. C., SCHAPIRA G., DEMOS J. [Study of serum creatine kinase in myopathic patients and their families]. Rev Fr Etud Clin Biol. 1960 Apr;5:384–386. [PubMed] [Google Scholar]
  4. DUBOWITZ V. MYOPATHIC CHANGES IN MUSCULAR DYSTROPHY CARRIERS. Proc R Soc Med. 1963 Sep;56:810–812. [PMC free article] [PubMed] [Google Scholar]
  5. Davie A. M., Emery A. E. Estimation of proportion of new mutants among cases of Duchenne muscular dystrophy. J Med Genet. 1978 Oct;15(5):339–345. doi: 10.1136/jmg.15.5.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dennis N. R., Evans K., Clayton B., Carter C. O. Use of creatine kinase for detecting severe X-linked muscular dystrophy carriers. Br Med J. 1976 Sep 4;2(6035):577–579. doi: 10.1136/bmj.2.6035.577. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dubowitz V. Letter: Genetic miscounselling in muscular dystrophy. Arch Dis Child. 1976 Apr;51(4):325–325. doi: 10.1136/adc.51.4.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Emery A. E. Duchenne muscular dystrophy. Genetic aspects, carrier detection and antenatal diagnosis. Br Med Bull. 1980 May;36(2):117–122. doi: 10.1093/oxfordjournals.bmb.a071624. [DOI] [PubMed] [Google Scholar]
  9. Emery A. E. Genetic counselling in X-linked muscular dystrophy. J Neurol Sci. 1969 May-Jun;8(3):579–587. doi: 10.1016/0022-510x(69)90016-1. [DOI] [PubMed] [Google Scholar]
  10. Emery A. E. Recombinant DNA technology. Lancet. 1981 Dec 19;2(8260-61):1406–1409. doi: 10.1016/s0140-6736(81)92814-2. [DOI] [PubMed] [Google Scholar]
  11. Emery A. E., Watt M. S., Clack E. R. The effects of genetic counselling in Duchenne muscular dystrophy. Clin Genet. 1972;3(2):147–150. doi: 10.1111/j.1399-0004.1972.tb01736.x. [DOI] [PubMed] [Google Scholar]
  12. FERRIER P., BAMATTER F., KLEIN D. MUSCULAR DYSTROPHY (DUCHENNE) IN A GIRL WITH TURNER'S SYNDROME. J Med Genet. 1965 Mar;2(1):38–46. doi: 10.1136/jmg.2.1.38. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gardner-Medwin D. Mutation rate in Duchenne type of muscular dystrophy. J Med Genet. 1970 Dec;7(4):334–337. doi: 10.1136/jmg.7.4.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gardner-Medwin D., Pennington R. J., Walton J. N. The detection of carriers of X-linked muscular dystrophy genes. A review of some methods studied in Newcastle upon Tyne. J Neurol Sci. 1971 Aug;13(4):459–474. doi: 10.1016/0022-510x(71)90008-6. [DOI] [PubMed] [Google Scholar]
  15. Gardner-Medwin D. Studies of the carrier state in the Duchenne type of muscular dystrophy. 2. Quantitative electromyography as a method of carrier detection. J Neurol Neurosurg Psychiatry. 1968 Apr;31(2):124–134. doi: 10.1136/jnnp.31.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gomez M. R., Engel A. G., Dewald G., Peterson H. A. Failure of inactivation of Duchenne dystrophy X-chromosome in one of female identical twins. Neurology. 1977 Jun;27(6):537–541. doi: 10.1212/wnl.27.6.537. [DOI] [PubMed] [Google Scholar]
  17. Hardy M. F., Gardner-Medwin D., Pennington R. J. Serum pyruvate kinase in carriers of Duchenne muscular dystrophy. J Neurol Sci. 1977 May;32(1):137–139. doi: 10.1016/0022-510x(77)90044-2. [DOI] [PubMed] [Google Scholar]
  18. Hausmanowa-Petrusewicz I., Prot J., Dobosz I., Emeryk B., Rowińska K., Rubach K., Kopeć A., Kopeć J. Further studies concerning the detection of carriership in the Duchenne type of dystrophy. Eur Neurol. 1971;5(3):186–196. doi: 10.1159/000114070. [DOI] [PubMed] [Google Scholar]
  19. Hausmanowa-Petrusewicz I., Prot J., Niebrój-Dobosz I., Hetnarska L., Emeryk B., Wasowicz B., Askanas W., Slucka C. Studies of healthy relatives of patients with Duchenne muscular dystrophy. J Neurol Sci. 1968 Nov-Dec;7(3):465–480. doi: 10.1016/0022-510x(68)90053-1. [DOI] [PubMed] [Google Scholar]
  20. Hutton E. M., Thompson M. W. Carrier detection and genetic counselling in Duchenne muscular dystrophy: a follow-up study. Can Med Assoc J. 1976 Oct 23;115(8):749–752. [PMC free article] [PubMed] [Google Scholar]
  21. Ionasescu V., Zellweger H., Shirk P., Conway T. W. Identification of carriers of Duchenne muscular dystrophy by muscle protein synthesis. Neurology. 1973 May;23(5):497–502. doi: 10.1212/wnl.23.5.497. [DOI] [PubMed] [Google Scholar]
  22. King B., Spikesman A., Emery A. E. The effect of pregnancy on serum levels of creatine kinase. Clin Chim Acta. 1972 Jan;36(1):267–269. doi: 10.1016/0009-8981(72)90191-x. [DOI] [PubMed] [Google Scholar]
  23. LYON M. F. Sex chromatin and gene action in the mammalian X-chromosome. Am J Hum Genet. 1962 Jun;14:135–148. [PMC free article] [PubMed] [Google Scholar]
  24. Lane R. J., Gardner-Medwin D., Roses A. D. Electrocardiographic abnormalities in carriers of Duchenne muscular dystrophy. Neurology. 1980 May;30(5):497–501. doi: 10.1212/wnl.30.5.497. [DOI] [PubMed] [Google Scholar]
  25. Lindenbaum R. H., Clarke G., Patel C., Moncrieff M., Hughes J. T. Muscular dystrophy in an X; 1 translocation female suggests that Duchenne locus is on X chromosome short arm. J Med Genet. 1979 Oct;16(5):389–392. doi: 10.1136/jmg.16.5.389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lymphocyte capping in Duchenne muscular dystrophy. N Engl J Med. 1979 Apr 12;300(15):861–862. doi: 10.1056/NEJM197904123001516. [DOI] [PubMed] [Google Scholar]
  27. Maunder-Sewry C. A., Dubowitz V. Needle muscle biopsy for carrier detection in Duchenne muscular dystrophy. Part 1. Light microscopy--histology, histochemistry and quantitation. J Neurol Sci. 1981 Feb;49(2):305–324. doi: 10.1016/0022-510x(81)90087-3. [DOI] [PubMed] [Google Scholar]
  28. Milhorat A. T., Shafiq S. A., Goldstone L. Changes in muscle structure in dystrophic patients, carriers and normal siblings seen by electron microscopy; correlation with levels of serum creatinephosphokinase (CPK). Ann N Y Acad Sci. 1966 Sep 9;138(1):246–292. doi: 10.1111/j.1749-6632.1966.tb41170.x. [DOI] [PubMed] [Google Scholar]
  29. Moosa A., Brown B. H., Dubowitz V. Quantitative electromyography: carrier detection in Duchenne type muscular dystrophy using a new automatic technique. J Neurol Neurosurg Psychiatry. 1972 Dec;35(6):841–844. doi: 10.1136/jnnp.35.6.841. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Moser H., Emery A. E. The manifesting carrier in Duchenne muscular dystrophy. Clin Genet. 1974;5(4):271–284. doi: 10.1111/j.1399-0004.1974.tb01694.x. [DOI] [PubMed] [Google Scholar]
  31. Percy M. E., Chang L. S., Murphy E. G., Oss I., Verellen-Dumoulin C., Thompson M. W. Serum creatine kinase and pyruvate kinase in Duchenne muscular dystrophy carrier detection. Muscle Nerve. 1979 Sep-Oct;2(5):329–339. doi: 10.1002/mus.880020503. [DOI] [PubMed] [Google Scholar]
  32. Radu H., Migea S., Török Z., Bordeianu L., Radu A. Carrier detection in X-linked Duchenne type muscular dystrophy. A pluridimensional investigation. J Neurol Sci. 1968 Mar-Apr;6(2):289–300. doi: 10.1016/0022-510x(68)90097-x. [DOI] [PubMed] [Google Scholar]
  33. Roses A. D., Roses M. J., Miller S. E., Hull K. L., Jr, Appel S. H. Carrier detection in Duchenne muscular dystrophy. N Engl J Med. 1976 Jan 22;294(4):193–198. doi: 10.1056/NEJM197601222940404. [DOI] [PubMed] [Google Scholar]
  34. Roses M. S., Nicholson M. T., Kircher C. S., Roses A. D. Evaluation and detection of Duchenne's and Becker's muscular dystrophy carriers by manual muscle testing. Neurology. 1977 Jan;27(1):20–25. doi: 10.1212/wnl.27.1.20. [DOI] [PubMed] [Google Scholar]
  35. Roy S., Dubowitz V. Carrier detection in Duchenne muscular dystrophy. A comparative study of electron microscopy, light microscopy and serum enzymes. J Neurol Sci. 1970 Jul;11(1):65–79. doi: 10.1016/0022-510x(70)90041-9. [DOI] [PubMed] [Google Scholar]
  36. Sage J., Inati Y., Samaha F. The importance of serum pyruvate kinase in neuromuscular diseases and carrier states. Muscle Nerve. 1979 Sep-Oct;2(5):390–393. doi: 10.1002/mus.880020511. [DOI] [PubMed] [Google Scholar]
  37. Seay A. R., Ziter F. A., Wu L. H., Wu J. T. Serum creatine phosphokinase and pyruvate kinase in neuromuscular disorders and Duchenne dystrophy carriers. Neurology. 1978 Oct;28(10):1047–1050. doi: 10.1212/wnl.28.10.1047. [DOI] [PubMed] [Google Scholar]
  38. Valli G., Scarlato G., Contartese M. Quantitative electromyography in the detection of the carriers in Duchenne type muscular dystrophy. J Neurol. 1976 Apr 23;212(2):139–149. doi: 10.1007/BF00329157. [DOI] [PubMed] [Google Scholar]
  39. WALTON J. N., RACE R. R., PHILIP U. On the inheritance of muscular dystrophy; with a note on the blood groups, and a note on colour vision and linkage studies. Ann Hum Genet. 1955 Aug;20(1):1–38. doi: 10.1111/j.1469-1809.1955.tb01274.x. [DOI] [PubMed] [Google Scholar]
  40. Yamuna S., Valmikinathan K., Burt D., Emery A. E. Serum pyruvate kinase in carriers of Duochenne muscular dystrophy. Clin Chim Acta. 1977 Aug 15;79(1):277–279. doi: 10.1016/0009-8981(77)90488-0. [DOI] [PubMed] [Google Scholar]
  41. Yoshioka M. Clinically manifesting carriers in Duchenne muscular dystrophy. Clin Genet. 1981 Jul;20(1):6–12. doi: 10.1111/j.1399-0004.1981.tb01799.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES